Article

Thrombotic microangiopathies: renal and extrarenal lesions.

Service de Néphrologie, Hôpital Necker, Paris, France.
Advances in nephrology from the Necker Hospital 02/2000; 30:235-59.
Source: PubMed
0 0
 · 
0 Bookmarks
 · 
21 Views
  • Article: A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy.
    Khalil El Karoui, Gary S Hill, Alexandre Karras, Christian Jacquot, Luc Moulonguet, Olivier Kourilsky, Véronique Frémeaux-Bacchi, Michel Delahousse, Jean-Paul Duong Van Huyen, Alexandre Loupy, Patrick Bruneval, Dominique Nochy
    [show abstract] [hide abstract]
    ABSTRACT: Thrombotic microangiopathy (TMA) occurs in IgA nephropathy, but its clinical significance is not well described. We retrospectively examined a series of 128 patients diagnosed with IgA nephropathy between 2002 and 2008 who had a mean follow-up of 44±27 months. In our series, 53% presented with lesions of TMA, acute or organized, in arteries and/or arterioles. Among patients with TMA, 4% were normotensive, 25% had controlled hypertension, and 71% had uncontrolled hypertension. Of those with uncontrolled hypertension, 26% had malignant hypertension. Histologically, the group with TMA had a significantly greater percentage of sclerotic glomeruli and worse tubulointerstitial fibrosis than those of the group without TMA. However, a significant minority of patients had near-normal histology, with minimal tubular atrophy (20%) and/or <20% interstitial fibrosis (24%). TMA rarely occurred in the absence of significant proteinuria. During follow-up, a doubling of serum creatinine or ESRD occurred in all patients with laboratory evidence of TMA, in 42% of those with morphologic evidence but no laboratory evidence of TMA, and in 11% of those without TMA. In summary, lesions of TMA are frequent in IgA nephropathy and may occur in normotensive patients with near-normal renal histology. Although the pathophysiologic mechanisms involved remain undetermined, the current study rules out severe hypertension or advanced renal disease as sole causes.
    Journal of the American Society of Nephrology 11/2011; 23(1):137-48. · 9.66 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

D Droz